StockData
BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc. (BTAIQ) stock

BTAIQOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$0.03−0.00 (-13.49%)

Close on Oct 19, 2026Market cap $757.50KP/E –Yield –

BioXcel Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

BioXcel Therapeutics's price to book ratio was 20.0× on Oct 31, 2023, against 2.1× a year earlier. Over the last 5 years it ranged from 1.3× to 25.2×, with a median of 4.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Oct 31, 202320.0×+15.3
2022Dec 30, 20224.7×+2.4
2021Dec 31, 20212.3×−2.8
2020Dec 31, 20205.1×−2.6
2019Dec 31, 20197.7×+6.3
2018Dec 31, 20181.3×–

More BioXcel Therapeutics figures

See a number that looks wrong?